Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Janet Prameela Dsouza, Jyothi Chakrabarty, Padmakumar Ramachandran, Vasudeva Guddattu, Baby S Nayak & Anice George. (2022) Effectiveness of a Nursing Intervention Module on Adherence, Knowledge, Quality of Life, and Complications Among Patients Receiving Anticoagulation therapy—a Randomized Controlled Trial Protocol. Patient Preference and Adherence 16, pages 1723-1731.
Read now
Read now
Muhammad Khalilur Rahman, Miraj Ahmed Bhuiyan & Suhaiza Zailani. (2021) Healthcare Services: Patient Satisfaction and Loyalty Lessons from Islamic Friendly Hospitals. Patient Preference and Adherence 15, pages 2633-2646.
Read now
Read now
Hillary J Mull, Marlena H Shin, Ryann L Engle, Amy M Linsky, Emily Kalver, Rebecca Lamkin & Jennifer L Sullivan. (2020) Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants. Patient Preference and Adherence 14, pages 1911-1922.
Read now
Read now
Kannan Sridharan, Rashed Al Banny, Ali Mohamed Qader, Aysha Husain & Kawther Mohamed Qader. (2020) Health-related quality of life in patients receiving oral anti-coagulants: a cross-sectional study. Expert Review of Cardiovascular Therapy 18:5, pages 309-314.
Read now
Read now
Diana Leh-Ching Ng, Gin-Gin Gan, Chee-Shee Chai, Kok-Han Chee, Kok-Leng Tan, Seng-Beng Tan & Ping-Chong Bee. (2019) Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study. Patient Preference and Adherence 13, pages 1363-1373.
Read now
Read now
Articles from other publishers (42)
Federica Troisi, Pietro Guida, Nicola Vitulano, Federico Quadrini, Antonio Di Monaco & Massimo Grimaldi. (2023) Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysis. International Journal of Cardiology 379, pages 40-47.
Crossref
Crossref
Adenike R Adelakun, Ricky D Turgeon, Mary A De Vera, Kimberlyn McGrail & Peter S Loewen. (2023) Oral anticoagulant switching in patients with atrial fibrillation: a scoping review. BMJ Open 13:4, pages e071907.
Crossref
Crossref
Catharina CM Kager, Maaike Horsselenberg, Joke C Korevaar, Cordula Wagner & Karin Hek. (2023) Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands. BJGP Open 7:1, pages BJGPO.2022.0179.
Crossref
Crossref
Samah W. Al-Jabi, Amal Abu Dalu, Amer A. Koni, Maher R. Khdour, Adham Abu Taha, Riad Amer & Sa’ed H. Zyoud. (2022) The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country. Thrombosis Journal 20:1.
Crossref
Crossref
Shahrzad Salmasi, Abdollah Safari, Anita Kapanen, Adenike Adelakun, Leanne Kwan, Jenny MacGillivray, Jason G. Andrade, Marc W. Deyell & Peter Loewen. (2022) Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study. Research in Social and Administrative Pharmacy 18:11, pages 3920-3928.
Crossref
Crossref
Souad Moudallel, Sven Laere, Pieter Cornu, Alain Dupont & Stephane Steurbaut. (2022) Assessment of adherence, treatment satisfaction and knowledge of direct oral anticoagulants in atrial fibrillation patients. British Journal of Clinical Pharmacology 88:5, pages 2419-2429.
Crossref
Crossref
Katarzyna Lomper, Maria Łoboz-Rudnicka, Tomasz Bańkowski, Krystyna Łoboz-Grudzień & Joanna Jaroch. (2022) The Influence of Frailty Syndrome and Dementia on the Convenience and Satisfaction with Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation. International Journal of Environmental Research and Public Health 19:9, pages 5355.
Crossref
Crossref
Heba Abu Hamdeh, Samah W. Al-Jabi, Amer Koni & Sa’ed H. Zyoud. (2022) Health-related quality of life and treatment satisfaction in Palestinians with rheumatoid arthritis: a cross-sectional study. BMC Rheumatology 6:1.
Crossref
Crossref
Yibo Wu, Shujie Dong, Xinyi Li, Haiping Xu & Xiaohui Xie. (2022) The Transcultural Adaptation and Validation of the Chinese Version of the Duke Anticoagulation Satisfaction Scale. Frontiers in Pharmacology 13.
Crossref
Crossref
Young-Soo Lee, Yong Seog Oh, Eue-Keun Choi, Alan Koay Choon Chern, Panyapat Jiampo, Aurauma Chutinet, Dicky Armein Hanafy, Prabhav Trivedi & Dongmei Zhai. (2021) Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study. Open Heart 8:2, pages e001745.
Crossref
Crossref
Dragos Vinereanu, Dmitry Napalkov, Jutta Bergler-Klein, Bela Benczur, Martin Ciernik, Nina Gotcheva, Alexey Medvedchikov, Pentti Põder, Dragan Simić, Andris Skride, Wenbo Tang, Maria Trusz-Gluza & Jiří Vesely. (2021) Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study. Journal of Thrombosis and Thrombolysis 52:4, pages 1195-1206.
Crossref
Crossref
Margriet Piersma‐Wichers, Tessa Elling, Anne M.B. de Vries‐Bots, Hilde A.M. Kooistra & Karina Meijer. (2021) Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation. Research and Practice in Thrombosis and Haemostasis 5:6, pages e12577.
Crossref
Crossref
Kateryna Fedorov, Swati Goel, Margarita Kushnir & Henny H. Billett. (2021) Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists. Research and Practice in Thrombosis and Haemostasis 5:6, pages e12574.
Crossref
Crossref
Stephanie L. Harrison, Asangaedem Akpan & Gregory Y. H. Lip. (2021) Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management. Journal of the American Geriatrics Society 69:7, pages 1807-1810.
Crossref
Crossref
Jackie Buck, Julia Fromings Hill, Alison Martin, Cassandra Springate, Bikramaditya Ghosh, Rachel Ashton, Gerry Lee & Andrzei Orlowski. (2021) Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review. Age and Ageing 50:4, pages 1108-1117.
Crossref
Crossref
Chun-Wei Lee, Ming-En Liu, Tsung-Ming Lee, Rei-Yeuh Chang, Chun-Yao Huang, Yu-Feng Hu & Hung-I Yeh. (2021) Patient satisfaction with dabigatrean and warfarin for stroke prevention in atrial fibrillation: Taiwan PASSION study. Journal of the Chinese Medical Association 84:4, pages 375-382.
Crossref
Crossref
Elena Ivany & Deirdre A. Lane. (2020) Patient Satisfaction: A Key Component in Increasing Treatment Adherence and Persistence. Thrombosis and Haemostasis 121:03, pages 255-257.
Crossref
Crossref
Vasyl Katerenchuk, Gonçalo S. Duarte, Gonçalo Martins e Pereira, Ricardo M. Fernandes, Joaquim J. Ferreira, Fausto J. Pinto, João Costa & Daniel Caldeira. (2020) Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis. Thrombosis and Haemostasis 121:03, pages 366-382.
Crossref
Crossref
Anna Zatloukalová, Miroslav Homza & Martina Kovalová. (2021) Compliance a kvalita života u pacientů s antikoagulační léčbou: první výsledky pilotní studie. Profese online 13:2, pages 36-45.
Crossref
Crossref
Sergio Cinza-Sanjurjo, Daniel Rey-Aldana, Manuel Portela-Romero & José R. González-Juanatey. (2021) Inercia terapéutica en anticoagulación oral en los pacientes con fibrilación auricular no valvular en atención primaria. Estudio ANFAGAL+. REC: CardioClinics 56:1, pages 22-29.
Crossref
Crossref
Souad Moudallel, Bart J.F. van den Bemt, Hanneke Zwikker, Anne de Veer, Silas Rydant, Liset van Dijk & Stephane Steurbaut. (2021) Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: A cross-sectional study in patients with atrial fibrillation. Patient Education and Counseling 104:1, pages 155-162.
Crossref
Crossref
Michele Magnocavallo, Antonio Bellasi, Marco Valerio Mariani, Maria Fusaro, Maura Ravera, Ernesto Paoletti, Biagio Di Iorio, Vincenzo Barbera, Domenico Giovanni Della Rocca, Roberto Palumbo, Paolo Severino, Carlo Lavalle & Luca Di Lullo. (2020) Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy. Journal of Clinical Medicine 10:1, pages 83.
Crossref
Crossref
Diana-Leh-Ching Ng, Natasya Marliana Bt Abdul Malik, Chee-Shee Chai, Greta-Miranda-Kim-Choo Goh, Seng-Beng Tan, Ping-Chong Bee, Gin-Gin Gan & Asri B. Said. (2020) Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
José Felipe Varona, José Miguel Seguí-Ripoll, Cristina Lozano-Duran, Luis Miguel Cuadrado-Gómez, Juan Bautista Montagud-Moncho, Antonio Ramos-Guerrero, José Carlos Mirete-Ferrer, Esther Donado & Javier García-Alegría. (2020) Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Arianna Magon, Cristina Arrigoni, Marco Moia, Michela Mancini, Federica Dellafiore, Duilio F. Manara & Rosario Caruso. (2020) Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonists. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Kun Zuo, Xiaoqing Liu, Pan Wang, Jie Jiao, Chunming Han, Zheng Liu, Xiandong Yin, Jing Li & Xinchun Yang. (2020) Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients. BMC Genomics 21:1.
Crossref
Crossref
Billy A. Caceres, Kathleen T. Hickey, Suzanne B. Bakken, Angelo B. Biviano, Hasan Garan, Isaac L. Goldenthal, Theresa A. Koleck, Ruth Masterson-Creber, Meghan Reading Turchioe & Haomiao Jia. (2020) Mobile Electrocardiogram Monitoring and Health-Related Quality of Life in Patients With Atrial Fibrillation. Journal of Cardiovascular Nursing 35:4, pages 327-336.
Crossref
Crossref
C. Ostrowka, L. Journeau, L. Plaisance, G. Poenou, S.E. Mecherour, H. Helfer & I. Mahé. (2020) Educational diagnosis of patients under oral anticoagulant therapy: Development of a 4-category patient profiling score based on a retrospective study and prospective analysis. JMV-Journal de Médecine Vasculaire 45:4, pages 184-191.
Crossref
Crossref
Jason P. Hecht, Zachary J. LaDuke, Anne H. Cain‐Nielsen, Mark R. Hemmila & Wendy L. Wahl. (2020) Effect of Preinjury Oral Anticoagulants on Outcomes Following Traumatic Brain Injury from Falls in Older Adults. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:7, pages 604-613.
Crossref
Crossref
Vivencio Barrios, Carlos Escobar, Juan José Gómez-Doblas, Jaime Fernández-Dueñas, Rafael Romero Garrido, Javier Pindado Rodríguez, Juana Umarán Sánchez, Eduardo Arellano-Rodrigo & Esther Donado. (2020) Patients’ perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists. Journal of Comparative Effectiveness Research 9:9, pages 615-625.
Crossref
Crossref
Jasper H.A. van Miert, Hilde A.M. Kooistra, Nic J.G.M. Veeger, Annelies Westerterp, Margriet Piersma-Wichers & Karina Meijer. (2020) Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN. Thrombosis Research 190, pages 69-75.
Crossref
Crossref
Dragos Vinereanu, Dmitry Napalkov, Jutta Bergler-Klein, Bela Benczur, Martin Ciernik, Nina Gotcheva, Alexey Medvedchikov, Pentti Põder, Dragan Simic, Andris Skride, Wenbo Tang, Maria Trusz-Gluza, Jiri Vesely, Tatiana Vishnepolsky & Mirej Vrabec. (2020) Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study). Open Heart 7:1, pages e001202.
Crossref
Crossref
Alan Yean Yip Fong, Lee Len Tiong, Shirley Siang Ning Tan, Dominic Geruka, Gerald Grino Apil, Chee Wei Choo & Tiong Kiam Ong. (2020) Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study. Clinical and Applied Thrombosis/Hemostasis 26, pages 107602962097247.
Crossref
Crossref
Saima Kishvar Afzal, Syed Shahzad Hasan & Zaheer Ud‐Din Babar. (2019) A systematic review of patient‐reported outcomes associated with the use of direct‐acting oral anticoagulants. British Journal of Clinical Pharmacology 85:12, pages 2652-2667.
Crossref
Crossref
M. Montero-Pérez-Barquero & L. Manzano. (2019) Quality of life, compliance and satisfaction of patients with atrial fibrillation who are undergoing anticoagulant treatment. Revista Clínica Española (English Edition) 219:6, pages 320-321.
Crossref
Crossref
V. Barrios, C. Escobar, G. Barón Esquivias, J.J. Gómez Doblas, E. Recalde del Vigo, L. Segura Martínez, P. Alvarez Garcia, F. Alonso Valladares, J. Toril Lopez & J.M. Chopo Alcubilla. (2019) Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists. Revista Clínica Española (English Edition) 219:6, pages 285-292.
Crossref
Crossref
M. Montero-Pérez-Barquero & L. Manzano. (2019) Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular en tratamiento anticoagulante. Revista Clínica Española 219:6, pages 320-321.
Crossref
Crossref
V. Barrios, C. Escobar, G. Barón Esquivias, J.J. Gómez Doblas, E. Recalde del Vigo, L. Segura Martínez, P. Alvarez Garcia, F. Alonso Valladares, J. Toril Lopez & J.M. Chopo Alcubilla. (2019) Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular tratados con dabigatrán o antagonistas de la vitamina K. Revista Clínica Española 219:6, pages 285-292.
Crossref
Crossref
Itziar Solla-Ruiz, Iñaki Villanueva-Benito, Emilio Paredes-Galán, Nahikari Salterain-González, Garazi Oria-González, Francisco De La Cuesta-Arzamendi & Ramón Querejeta-Iraola. (2019) Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study. Thrombosis Research 179, pages 20-27.
Crossref
Crossref
Sylvia Haas, A John Camm, Jean-Pierre Bassand, Pantep Angchaisuksiri, Frank Cools, Ramon Corbalan, Harry Gibbs, Barry Jacobson, Yukihiro Koretsune, Lorenzo G Mantovani, Frank Misselwitz, Elizaveta Panchenko, Hany Ibrahim Ragy, Janina Stepinska, Alexander GG Turpie, Jitendra PS Sawhney, Jan Steffel, Toon Wei Lim, Karen S Pieper, Saverio Virdone, Freek WA Verheugt & Ajay K Kakkar. (2019) Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. American Heart Journal 213, pages 35-46.
Crossref
Crossref
Jonathan Gospos & Nijole Bernaitis. (2019) Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia. Journal of Clinical Medicine 8:6, pages 863.
Crossref
Crossref
Saurabh Gupta, Kevin J. Um, Arjun Pandey, William F. McIntyre, Marina Ivanova, Yasamin Allahverdi, Parisa Agahi, Feny Pandya, Ana Lopez, Amrit Sachdeva, Richard P. Whitlock & Emilie P. Belley-Cote. (2019) Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovascular Drugs and Therapy 33:3, pages 339-352.
Crossref
Crossref